Literature DB >> 7972685

Thyroid cancer after radiotherapy for skin hemangioma in infancy.

M Lundell1, T Hakulinen, L E Holm.   

Abstract

A Swedish cohort of 14,351 infants exposed to ionizing radiation for skin hemangioma was analyzed with respect to thyroid cancer risk. The subjects were irradiated during the period 1920-1959 and radiotherapy was given with beta particles, gamma rays and/or X rays. The mean absorbed dose to the thyroid was 0.26 Gy (range < 0.01-28.5 Gy). The cohort was matched with the Swedish Cancer Register for the period 1958-1986. Seventeen thyroid cancers were registered (standardized incidence ratio = 2.28; 95% confidence interval 1.33-3.65), and the mean thyroid absorbed dose in those subjects was 1.07 Gy (range < 0.01-4.34 Gy). The effect of different variables on the incidence of thyroid cancer was evaluated with Poisson regression. The excess in thyroid cancer began 19 years after radiotherapy and persisted at least 40 years after irradiation. A statistically significant dose-response relationship was found. The excess relative risk per gray was 4.92 (95% CI 1.26-10.2) and the excess absolute risk was 0.90 x 10(-4) per person-year gray. No significant difference in excess relative or absolute risk could be seen between the sexes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972685

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  17 in total

Review 1.  Effects of radiation exposure from cardiac imaging: how good are the data?

Authors:  Andrew J Einstein
Journal:  J Am Coll Cardiol       Date:  2012-02-07       Impact factor: 24.094

2.  Nuclear energy and health: and the benefits of low-dose radiation hormesis.

Authors:  Jerry M Cuttler; Myron Pollycove
Journal:  Dose Response       Date:  2008-11-10       Impact factor: 2.658

3.  Risks associated with low doses and low dose rates of ionizing radiation: why linearity may be (almost) the best we can do.

Authors:  Mark P Little; Richard Wakeford; E Janet Tawn; Simon D Bouffler; Amy Berrington de Gonzalez
Journal:  Radiology       Date:  2009-04       Impact factor: 11.105

4.  Radiotherapy for childhood cancer and subsequent thyroid cancer risk: a systematic review.

Authors:  Eva Lorenz; Peter Scholz-Kreisel; Dan Baaken; Roman Pokora; Maria Blettner
Journal:  Eur J Epidemiol       Date:  2018-12-04       Impact factor: 8.082

5.  No thyroid abnormalities in patients submitted to cardiac catheterization in the first eighteen months of life.

Authors:  M Cappa; P Cambiaso; E Genovese; D Kiepe; M Colajacomo; S Giannico; G Giannone; R Guglielmi; L Papini; V Cannatà
Journal:  J Endocrinol Invest       Date:  2011-12-21       Impact factor: 4.256

6.  Array comparative genomic hybridisation analysis of gamma-irradiated human thyrocytes.

Authors:  Stephen P Finn; Paul Smyth; Esther O'regan; Susanne Cahill; Richard Flavin; John O'leary; Orla Sheils
Journal:  Virchows Arch       Date:  2004-07-17       Impact factor: 4.064

7.  Thyroid Cancer after Childhood Exposure to External Radiation: An Updated Pooled Analysis of 12 Studies.

Authors:  Lene H S Veiga; Erik Holmberg; Harald Anderson; Linda Pottern; Siegal Sadetzki; M Jacob Adams; Ritsu Sakata; Arthur B Schneider; Peter Inskip; Parveen Bhatti; Robert Johansson; Gila Neta; Roy Shore; Florent de Vathaire; Lena Damber; Ruth Kleinerman; Michael M Hawkins; Margaret Tucker; Marie Lundell; Jay H Lubin
Journal:  Radiat Res       Date:  2016-04-29       Impact factor: 2.841

Review 8.  A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction.

Authors:  X George Xu; Bryan Bednarz; Harald Paganetti
Journal:  Phys Med Biol       Date:  2008-06-09       Impact factor: 3.609

Review 9.  Do non-targeted effects increase or decrease low dose risk in relation to the linear-non-threshold (LNT) model?

Authors:  M P Little
Journal:  Mutat Res       Date:  2010-01-25       Impact factor: 2.433

10.  Radiation associated tumors following therapeutic cranial radiation.

Authors:  Abhineet Chowdhary; Alex M Spence; Lindsay Sales; Robert C Rostomily; Jason K Rockhill; Daniel L Silbergeld
Journal:  Surg Neurol Int       Date:  2012-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.